Literature DB >> 11979400

Lipid peroxidation and protein modification in a mouse model of chronic iron overload.

Mark A Sochaski1, Wally J Bartfay, Suzanne R Thorpe, John W Baynes, Emma Bartfay, Denis C Lehotay, Peter P Liu.   

Abstract

Iron-storage diseases are believed to cause organ damage through generation of reactive oxygen species. Using a murine model of iron overload, we found that hepatic iron stores increased logarithmically during 3 weeks of chronic intraperitoneal administration of iron dextran, while hepatic glutathione peroxidase activity declined linearly by approximately 50% during the same period. Plasma concentrations of aliphatic aldehydes increased by 2- to 3-fold, and plasma malondialdehyde (MDA) by 6-fold. Modification of total liver protein by products of lipid peroxidation, including MDA-lysine, 4-hydroxynonenal-lysine, and N(epsilon)-(carboxymethyl)lysine (CML), increased by approximately 3-fold, while levels of the protein oxidation marker, methionine sulfoxide (MetSO), were unchanged. Skin collagen was resistant to modification until the third week, when 2- to 3-fold increases in both CML and MetSO were observed. Our results document that iron overload increases lipid peroxidation, with concomitant increases in reactive aldehydes in plasma and chemical modification of tissue proteins. CML was a sensitive indicator of hepatocellular oxidative stress, compared to MetSO, while extensive modification of extracellular skin collagen was not observed until the late stages of iron overload and oxidative stress. These observations provide direct evidence for the contribution of reactive oxygen species, lipid peroxidation, and reactive carbonyl intermediates to the pathogenesis of iron-overload diseases. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979400     DOI: 10.1053/meta.2002.30530

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Comparative study between Hfe-/- and beta2m-/- mice: progression with age of iron status and liver pathology.

Authors:  Pedro Rodrigues; Célia Lopes; Claudia Mascarenhas; Paolo Arosio; Graça Porto; Maria De Sousa
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

2.  Efficacy and safety of 6-month iron reduction therapy in patients with hepatitis C virus-related cirrhosis: a pilot study.

Authors:  Naoki Tanaka; Akira Horiuchi; Takahiro Yamaura; Michiharu Komatsu; Eiji Tanaka; Kendo Kiyosawa
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

3.  Nrf2-activating Therapy Accelerates Wound Healing in a Model of Cutaneous Chronic Venous Insufficiency.

Authors:  Joseph Kuhn; Darren L Sultan; Bukhtawar Waqas; Trevor Ellison; Jennifer Kwong; Camille Kim; Absara Hassan; Piul S Rabbani; Daniel J Ceradini
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-11-20

4.  Ferritin Level Is Positively Associated with Chronic Kidney Disease in Korean Men, Based on the 2010-2012 Korean National Health and Nutrition Examination Survey.

Authors:  Hee-Taik Kang; John A Linton; Soon Kil Kwon; Byoung-Jin Park; Jong Hun Lee
Journal:  Int J Environ Res Public Health       Date:  2016-10-29       Impact factor: 3.390

5.  Protective Effects of Acridocarpus smeathmannii (DC.) Guill. & Perr. Root Extract against Phenylhydrazine-Induced Haematotoxicity, Biochemical Changes, and Oxidative Stress in Rats.

Authors:  Oluwafemi Ezekiel Kale; Olufunsho Awodele; Abidemi James Akindele
Journal:  Biochem Insights       Date:  2019-11-06

Review 6.  The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders.

Authors:  Pamela J Urrutia; Natalia P Mena; Marco T Núñez
Journal:  Front Pharmacol       Date:  2014-03-10       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.